Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses.
Wang M, Rousseau B, Qiu K, Huang G, Zhang Y, Su H, Le Bihan-Benjamin C, Khati I, Artz O, Foote MB, Cheng YY, Lee KH, Miao MZ, Sun Y, Bousquet PJ, Hilmi M, Dumas E, Hamy AS, Reyal F, Lin L, Armistead PM, Song W, Vargason A, Arthur JC, Liu Y, Guo J, Zhou X, Nguyen J, He Y, Ting JP, Anselmo AC, Huang L.
Wang M, et al. Among authors: arthur jc.
Nat Biotechnol. 2024 Aug;42(8):1263-1274. doi: 10.1038/s41587-023-01957-8. Epub 2023 Sep 25.
Nat Biotechnol. 2024.
PMID: 37749267